Medivatus Group ApS: Financial statements 2022
CVR: 40644482
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Medivatus Group ApS (CVR 40644482) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 958,309 and a net result of DKK 2,080,371 compared with DKK -2,191,695 the year before. That is a decrease of 46.1% compared with the year before. Equity in the 2022 report amounted to DKK 1,206,494. The solvency ratio was 73.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 958,309
- Profit/Loss
- DKK 2,080,371
- Equity
- DKK 1,206,494
- Total Assets
- DKK 1,642,048
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 958 t. | 2.1 mio. | 1.2 mio. | 1 |
| 2021 | - | 1.8 mio. | -2.2 mio. | -883 t. | 2 |
| 2020 | - | 400 t. | 704 t. | 1.3 mio. | 1 |
Official annual report
Keep an eye on Medivatus Group ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 16, 2022, is registered as an owner of Medivatus Group ApS with an ownership share of 100%.
Medivatus Group ApS has published its annual report for 2021. Gross profit came to DKK 1,777,591, and the net result was DKK -2,191,695.
About Medivatus Group ApS
Medivatus Group ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Helle Katrine Jørgensen and David Gareth Martin. The company is owned by Assegai Holding AS. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -32,614 compared with DKK -297,261 the year before. Equity in the 2025 report amounted to DKK 215,753.